Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 4 3Phase NA 2Phase 2 2Phase 1 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Breast 1

Conditions

Pain 6Neoplasms 3Neoplasm Metastasis 2Cancer Pain 2Breast Neoplasms 2Wounds and Injuries 1Pleural Effusion, Malignant 1Pain, Postoperative 1Mucositis 1Lung Neoplasms 1Leiomyoma 1Ileus 1Head and Neck Neoplasms 1Agnosia 1

Interventions

Morphine 2resiniferatoxin 1incobotulinumtoxinA 1fulranumab 1cannabichromene 1alvimopan 1Tablets 1Surveys and Questionnaires 1Standard of Care 1Pain Management 1Oxycodone 1Occupational Therapy 1Massage 1Lidocaine 1Lenalidomide 1Ketamine 1Gels 1Fentanyl 1Dronabinol 1Cannabidiol 1Animal Assisted Therapy 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Cancer Pain × Morphine × Clear all
NCT05800834 2023-09-28

MorphineGEL

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown
106 enrolled
BreastHead & Neck

Cancer Pain, Breast Neoplasms, Head and Neck Neoplasms, Wounds and Injuries

NCT04243954 2021-03-05

Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration

Fujian Cancer Hospital

Phase 2 Completed
95 enrolled

Cancer Pain, Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡